Radiation Protection Dosimetry Advance Access originally published online on February 3, 2006
Radiation Protection Dosimetry 2005 117(1-3):225-230; doi:10.1093/rpd/nci753
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dose conversion coefficients for interventional procedures
Interfaculty Reactor Institute, Delft University of Technology, Mekelweg 15, NL-2629 JB Delft, The Netherlands
* Corresponding author: f.w.schultz{at}tnw.tudelft.nl
Effective dose (E) is a convenient quantity to estimate the stochastic risk of radiation applied to patients in interventional procedures and can be used for optimisation. Relatively long exposure times may cause deterministic effects. Hence it is necessary to know the (maximum local) doses in organs owing to the interventional procedure. In practice, organ doses cannot be measured directly. They are derived by applying a conversion coefficient to a measurable quantity, e.g. dosearea product (DAP) or entrance skin dose. For a number of interventional procedures, dose conversion coefficients (DCCs) can be found in the literature. Various DCCs are stated for nominally equal procedures, e.g. for percutaneous transluminal coronary angioplasty both 0.18 and 0.27 mSv Gy1 cm2 were reported to convert DAP to effective dose. Dependence of DCC on protocol and equipment parameters, as demonstrated through Monte Carlo simulation in this paper, makes it hazardous to simply adopt a literature value.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Kim, G. Toncheva, C. Anderson-Evans, B. K. Huh, L. Gray, and T. Yoshizumi Kerma Area Product Method for Effective Dose Estimation During Lumbar Epidural Steroid Injection Procedures: Phantom Study Am. J. Roentgenol., June 1, 2009; 192(6): 1726 - 1730. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kriatselis, M. Tang, M. Roser, E. Fleck, and H. Gerds-Li A new approach for contrast-enhanced X-ray imaging of the left atrium and pulmonary veins for atrial fibrillation ablation: rotational angiography during adenosine-induced asystole Europace, January 1, 2009; 11(1): 35 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bogaert, K. Bacher, and H. Thierens INTERVENTIONAL CARDIOVASCULAR PROCEDURES IN BELGIUM: EFFECTIVE DOSE AND CONVERSION FACTORS Radiat Prot Dosimetry, April 2, 2008; (2008) ncn021v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Dragusin, M. Gewillig, W. Desmet, K. Smans, L. Struelens, and H. Bosmans Radiation dose survey in a paediatric cardiac catheterisation laboratory equipped with flat-panel detectors Radiat Prot Dosimetry, March 1, 2008; 129(1-3): 91 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bogaert, K. Bacher, and H. Thierens A large-scale multicentre study in Belgium of dose area product values and effective doses in interventional cardiology using contemporary X-ray equipment Radiat Prot Dosimetry, February 1, 2008; 128(3): 312 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ector, O. Dragusin, B. Adriaenssens, W. Huybrechts, R. Willems, H. Ector, and H. Heidbuchel Obesity Is a Major Determinant of Radiation Dose in Patients Undergoing Pulmonary Vein Isolation for Atrial Fibrillation J. Am. Coll. Cardiol., July 17, 2007; 50(3): 234 - 242. [Abstract] [Full Text] [PDF] |
||||



